About Dan Albosta
Form D filings for Spinogenix in 2024 list Dan Albosta as executive officer.
Dan Albosta first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Dan Albosta in the role, so the role may have started earlier or lasted longer.
Spinogenix, Inc.
Executive officer
2024 · Los Angeles, CA
Develops experimental medicines for people with neurological and psychiatric conditions.
Key Colleagues at Startups
The people Dan Albosta works with at each company, as listed on that company's latest Form D.
Spinogenix, Inc. · Form D, Jun 21, 2024
MT
Mervyn Turner
Director
SS
Stella Sarraf
Executive officer and director
PV
Peter Vanderklish
Executive officer
Jerre Stead
Director